**Question:** Drug of choice for chronic hepatitis -B is

A. Lamivudine
B. Adefovir
C. Entecavir
D. Tenofovir

**Correct Answer:** D. Tenofovir

**Core Concept:** Chronic Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), which can lead to liver inflammation, scarring, and potentially liver cancer. Antiviral medications are used to suppress the virus and prevent liver damage.

**Why the Correct Answer is Right:** Tenofovir (DFT) is a nucleoside analog reverse transcriptase inhibitor that is highly effective against HBV replication. It effectively suppresses viral load, prevents viral resistance, and reduces the risk of liver-related complications. Tenofovir is also well-tolerated, with fewer side effects compared to older antiviral drugs.

**Why Each Wrong Option is Incorrect:**

A. Lamivudine (Emtricitabine) is a nucleoside analog reverse transcriptase inhibitor that is effective against HBV, but it has a higher risk of viral resistance compared to Tenofovir. Resistance develops more rapidly with Lamivudine, which can lead to treatment failure.

B. Adefovir (Pentamidine) is a nucleoside analog reverse transcriptase inhibitor, but it is less potent against HBV than Tenofovir. Adefovir is also less effective in suppressing viral load and reducing the risk of liver-related complications.

C. Entecavir is a nucleoside analog reverse transcriptase inhibitor, similar to Tenofovir. However, Entecavir has a higher risk of resistance development compared to Tenofovir, especially in patients with chronic hepatitis B.

**Clinical Pearl:** In chronic hepatitis B treatment, the choice of antiviral drug depends on the patient's history of previous treatment and resistance patterns. Tenofovir is the preferred option in patients with previous Lamivudine or Adefovir resistance due to its superior efficacy and resistance profile.

**Explanation:**

**Core Concept:** Chronic Hepatitis B is a viral infection caused by the hepatitis B virus (HBV), which can lead to liver inflammation, scarring, and potentially liver cancer. Antiviral medications are used to suppress HBV replication, preventing liver damage and liver-related complications.

**Why the Correct Answer is Right:** Tenofovir (TDF) is a nucleoside analog reverse transcriptase inhibitor that is highly effective in suppressing HBV replication and reducing the risk of liver-related complications. It has a low risk of resistance development, which is crucial in long-term treatment. Tenofovir is also less likely to cause renal toxicity compared to other antiviral drugs.

**Why Each Wrong Option is Incorrect:**

Adefovir (Pentamidine) is a nucleoside analog reverse transcriptase inhibitor, but it is less potent than Tenofovir and has a higher risk of resistance development. Adefovir can also cause renal toxicity, which is a concern in patients with pre-existing renal impairment.

Entecav